Shares of Gilead Sciences Inc. GILD, -0.35% slid 1.44% to $59.66 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX, -1.57% falling 0.63% to 4,602.45 and Dow Jones Industrial Average DJIA, -1.56% falling 0.19% to 35,228.81. The stock’s fall snapped a two-day winning streak. Gilead Sciences Inc. closed $14.46 short of its 52-week high ($74.12), which the company achieved on December 30th.
The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson JNJ, -1.31% rose 1.04% to $179.59, Merck & Co. Inc. MRK, -0.42% rose 1.02% to $82.40, and AbbVie Inc. ABBV, -1.00% rose 0.97% to $163.75. Trading volume (8.6 M) remained 3.5 million below its 50-day average volume of 12.1 M.